Selected article for: "acute infection symptom and long covid"

Author: Sahanic, S.; Tymoszuk, P.; Ausserhofer, D.; Rass, V.; Pizzini, A.; Nordmeyer, G.; Hampuumlfner, K.; Kurz, K.; Weber, P. M.; Sonnweber, T.; Boehm, A.; Aichner, M.; Cima, K.; Boeckle, B.; Holzner, B.; Rumpold, G.; Puelacher, C.; Kiechl, S.; Huber, A.; Wiedermann, C. J.; Sperner-Unterweger, B.; Tancevski, I.; Bellmann-Weiler, R.; Bachler, H.; Piccoliori, G.; Helbok, R.; Weiss, G.; Loeffler-Ragg, J.
Title: Phenotyping of acute and persistent COVID-19 features in the outpatient setting: exploratory analysis of an international cross-sectional online survey
  • Cord-id: wn4kdip8
  • Document date: 2021_8_7
  • ID: wn4kdip8
    Snippet: BACKGROUND. Long COVID, defined as presence of COVID-19 related symptoms 28 days or more after the onset of acute SARS-CoV-2 infection, is an emerging challenge to healthcare systems. The objective of this study was to phenotype recovery trajectories of non-hospitalized COVID-19 individuals. METHODS. We performed an international, multi-center, exploratory online survey study on demographics, comorbidities, COVID-19 symptoms and recovery status of non-hospitalized SARS-CoV-2 infected adults (Aus
    Document: BACKGROUND. Long COVID, defined as presence of COVID-19 related symptoms 28 days or more after the onset of acute SARS-CoV-2 infection, is an emerging challenge to healthcare systems. The objective of this study was to phenotype recovery trajectories of non-hospitalized COVID-19 individuals. METHODS. We performed an international, multi-center, exploratory online survey study on demographics, comorbidities, COVID-19 symptoms and recovery status of non-hospitalized SARS-CoV-2 infected adults (Austria: n=1157), and Italy: n= 893). RESULTS. Working age subjects (Austria median: 43 yrs (IQR: 31 - 53), Italy: 45 yrs (IQR: 35 - 55)) and females (65.1% and 68.3%) predominated the study cohorts. Course of acute COVID-19 was characterized by a high symptom burden (median 13 (IQR: 9 - 18) and 13 (7 - 18) out of 44 features queried), a 47.6 - 49.3% rate of symptom persistence beyond 28 days and 20.9 - 31.9% relapse rate. By cluster analysis, two acute symptom phenotypes could be discerned: the non-specific infection phenotype and the multi-organ phenotype (MOP), the latter encompassing multiple neurological, cardiopulmonary, gastrointestinal and dermatological features. Clustering of long COVID subjects yielded three distinct subgroups, with a subset of 48.7 - 55 % long COVID individuals particularly affected by post-acute MOP symptoms. The number and presence of specific acute MOP symptoms and pre-existing multi-morbidity was linked to elevated risk of long COVID. CONCLUSION. The consistent findings of two independent cohorts further delineate patterns of acute and post-acute COVID-19 and emphasize the importance of symptom phenotyping of home-isolated COVID-19 patients to predict protracted convalescence and to allocate medical resources.

    Search related documents:
    Co phrase search for related documents
    • ace inhibitor and long covid: 1, 2, 3
    • ace inhibitor and long covid risk: 1, 2
    • acute describe and long covid: 1, 2, 3, 4, 5, 6, 7
    • acute describe and long covid describe: 1
    • acute describe and long covid risk: 1
    • acute illness and long covid: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute illness and long covid describe: 1, 2
    • acute illness and long covid risk: 1
    • acute infection and long covid: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute infection and long covid describe: 1, 2, 3
    • acute infection and long covid risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute symptom and long covid: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • acute symptom and long covid risk: 1, 2, 3